Top Markets
Coin of the day
Theraclion SA Theraclion SA

Theraclion SA

ALTHE
Rank in Stocks #15409
Theraclion SA develops echotherapy solutions using high intensity focused... Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
Share Price
$0.78404857
Market Cap
$36.98M
Change (1 day)
-1.49%
Change (1 year)
139.26%
Country
FR
Trade Theraclion SA (ALTHE)

Category

P/B ratio for Theraclion SA (ALTHE)
P/B ratio as of July 2026 TTM: -14.11
According to Theraclion SA latest financial reports and stock price the company's current price-to-book ratio (TTM) is -14.11. At the end of 2023 the company had a P/B ratio of 3.14.
P/B ratio history for Theraclion SA from 2010 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) -14.11 -99.99%
2024 -133.83K -4,259,251.68%
2023 3.14 -93.56%
2022 48.76 -308.04%
2021 -23.44 132.26%
2020 -10.09 -96.80%
2019 -315.54 2,868.09%
2018 -10.63 -221.88%
2017 8.72 44.54%
2016 6.03 -82.25%
2015 34.00 228.35%
2014 10.36 -210.01%
2013 -9.41 -107.46%
2012 126.12 -59.55%
2011 311.80 959.96%
2010 29.42 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
3.0429 -121.56%
US
5.2455 -137.17%
US
2.0273 -114.37%
IE
2.4503 -117.36%
US
5.0733 -135.95%
US